Clinical Trial Update: Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study [NA]

View source ↗

Summary

A completed clinical trial evaluating absorption and safety with sustained use of RELiZORB in cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• RELiZORB

Snippet

Sponsor: Alcresta Therapeutics, Inc. | Conditions: Cystic Fibrosis | NA | Status: COMPLETED | Results posted: 2018-07-18